针对三阴性乳腺癌的分裂与征服向治疗
Milica Nedeljković1, Ana Vuletić1, Katarina Mirjačić Martinović1
1Department of Experimental Oncology, Institute for Oncology and Radiology of Serbia, 11000 Belgrade, Serbia.
International journal of molecular sciences
|February 26, 2025
概括
三阴性乳腺癌 (TNBC) 是具有不良结果的侵略性. 了解其分子亚型,可以实现针对特定途径的个性化治疗,以改善药物敏感性和患者预后.
科学领域:
- 在瘤学瘤学.
- 基因组学就是基因组学.
- 分子生物学分子生物学
背景情况:
- 三阴性乳腺癌 (TNBC) 是一种具有高度攻击性的恶性瘤,治疗选择有限.
- TNBC表现出显著的分子异质性,其特点是不同的亚型.
- 这种异质性使治疗策略复杂化,并导致患者预后不佳.
研究的目的:
- 审查有关TNBC分子亚型的当前知识.
- 探索如何理解这些亚型可以为定制的治疗策略提供信息.
- 突出新的向药物和TNBC的治疗方式.
主要方法:
- 文献综述侧重于TNBC分子亚型.
- 对驱动TNBC的明显突变和途径异常的分析.
- 检查目标药物和治疗方式.
主要成果:
- 在TNBC中识别了几种不同的分子亚型.
- 特定分子特征与临床行为和药物敏感性的关联.
- 针对性治疗的概述,重点关注关键信号通路.
结论:
- 基于TNBC分子亚型的量身定制的治疗策略至关重要.
- 准特定的途径,如雄激素受体,PI3K/AKT和生长因子信号显示有希望.
- 免疫疗法是TNBC的关键新兴治疗方式.
关键词:
欧洲农业基金会 (EGFR) 是一个基金.在JAK/STAT路径中.这是一种PARP抑制剂.通过PI3K/AKT路径.在TGF-β路径中.在VEGFR中,VEGFR是VEGFR.在Wnt/β-catenin路径中.受体受体是受体的受体.免疫检查点抑制剂 免疫检查点抑制剂免疫疗法 免疫疗法分子亚型 分子亚型口路径 口路径三重阴性乳腺癌是什么更多相关视频
10:27Testing Targeted Therapies in Cancer using Structural DNA Alteration Analysis and Patient-Derived Xenografts
Published on: July 25, 2020
7.2K
14:20Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
16.6K
相关概念视频
02:57Targeted Cancer Therapies
7.4K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.4K
02:50Combination Therapies and Personalized Medicine
4.8K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.8K